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A B S T R A C T   
Various Cognitive Behavioral Therapy (CBT) programs for externalizing disorders in children and adolescents are 
supported by a substantial body of empirical evidence. Most of the research evidence comes from efficacy studies 
conducted in university settings, but there is less knowledge about the effect of these treatments in routine 
clinical care. The purpose of this meta-analysis was to investigate the effectiveness of CBT in non-university 
settings for Attention Deficit Hyperactivity Disorder (ADHD), Conduct Disorder (CD) and Oppositional Defiant 
Disorder (ODD). Embase OVID, Ovid MEDLINE and PsycINFO were systematically searched for eligible studies 
published up to May 2020. In total, 51 treatment effectiveness studies involving 5295 patients were included. 
The average within-group effect size at post-treatment was significant (g = 0.91), and there were large effect sizes 
for both ADHD (g = 0.80) and CD/ODD (g = 0.98). At post treatment, remission rates were 38% for ADHD and 
48% for CD/ODD, and the overall attrition rate was 14%. Benchmarking against efficacy studies showed that CBT 
in routine clinical care yields remission rates, within-group effect sizes and attrition rates that are very similar to 
those found in university settings. The findings support the transportability of CBT for externalizing disorders 
from university settings to routine clinical care. 
PROSPERO registration: CRD42020147524.   
Externalizing behavior disorders are among the most common rea-
sons for referral to mental health services for children and adolescents 
and include the diagnoses of Attention Deficit Hyperactivity Disorder 
(ADHD), Conduct Disorder (CD) and Oppositional Defiant Disorder 
(ODD). ADHD has an estimated prevalence of 7.2% (Thomas, Sanders, 
Doust, Beller, & Glasziou, 2015) whereas CD and ODD have estimated 
prevalence rates of 3.5% and 2.8%, respectively (O’Connell, Boat, & 
Warner, 2009). Although ADHD is classified as a neurodevelopmental 
disorder and CD and ODD as disruptive behavior disorders they are all 
characterized by problems with aggression, impulse-control and rule- 
breaking behavior. Children with externalizing disorders have poorer 
academic and social functioning than other children (Clark, Prior, & 
Kinsella, 2002; DuPaul, Morgan, Farkas, Hillemeier, & Maczuga, 2016) 
and have a higher risk of negative outcomes in adulthood, including an 
increased risk of unemployment, criminality, financial problems, and 
increased mortality rates (Franke et al., 2018; Scott et al., 2017). They 
are also at a higher risk of developing emotional problems, as exter-
nalizing disorders are highly comorbid with both anxiety and depres-
sion, which appears to lead to more severe impairment than when 
children are diagnosed with either disorder alone (Jarrett & Ollendick, 
2008; Schatz & Rostain, 2006; Wolff & Ollendick, 2006). Furthermore, 
this vulnerability for the development of emotional disorders appears to 
be present in adulthood as well, as childhood ODD has been found to 
predict depression in young adulthood (Copeland, Shanahan, Costello, 
& Angold, 2009). The relatively high prevalence of externalizing dis-
orders and the severe consequences for the individual and the society 
highlights the necessity of providing evidence-based interventions. 
Various treatment programs for externalizing disorders have been 
supported by findings from numerous randomized controlled trials 
(RCTs). There is evidence for the efficacy of a wide range of CBT- 
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oriented treatments. Programs with well-established efficacy for exter-
nalizing disorders include behavior therapy programs for parents, chil-
dren and/or teachers and cognitive interventions aimed at increasing 
children’s self-control and problem solving skills as well as programs 
addressing the organizational problems of children with ADHD (Evans, 
Owens, & Bunford, 2014; Kaminski & Claussen, 2017; McCart & 
Sheidow, 2016). Although it is encouraging that a growing body of 
methodologically sound trials are carried out, it has been argued that 
more attention should be directed at investigations of clinical effec-
tiveness in routine clinical care (Tolin, McKay, Forman, Klonsky, & 
Thombs, 2015). Efficacy trials from university settings are often carried 
out with a methodologically stringent procedure which produces results 
with high internal validity. However, the circumstances in such trials 
may differ from “real world” clinical settings. For instance, participants 
are usually actively recruited through advertisements and willing to risk 
being randomized to a control condition. Also, it is common for efficacy 
studies to apply more exclusion criteria in order to obtain a more ho-
mogenous sample of participants. ADHD is, for example, highly co-
morbid with other disorders (e.g. Owens & Hinshaw, 2013; Steinhausen 
et al., 2006) and a comorbid diagnosis of ADHD and ODD or CD has been 
found to increase the severity of ADHD symptoms (Efron, Bryson, Lycett, 
& Sciberras, 2016; Jerrell, McIntyre, & Park, 2015; Takeda, Ambrosini, 
deBerardinis, & Elia, 2012). Similarly, children and adolescents with CD 
are frequently diagnosed with comorbid depression and typically show 
greater impairment than children diagnosed with either disorder alone 
(Wolff & Ollendick, 2006). This could result in patients in efficacy trials 
having less severe symptoms and that the sample may not be repre-
sentative of patients in routine clinical settings. Furthermore, the ther-
apists involved in efficacy trials are often experts in the intervention 
under investigation, and are dedicated part- or full time to the research 
project as opposed to clinicians in routine care who carry large caseloads 
with a variety of disorders. The differences between university settings 
and routine clinical care suggest that findings from methodologically 
stringent efficacy trials may not be transferable to clinical practice. 
Previous reviews comparing studies from routine clinical care to 
efficacy studies from university settings have shown different results for 
different disorders. A meta-analysis of effectiveness studies for children 
with autism spectrum disorder found smaller effect-sizes for community- 
based studies than for university-based clinical trials, indicating a gap 
between research settings and routine clinical care (Nahmias, Pellec-
chia, Stahmer, & Mandell, 2019). Conversely, in a recent meta-analysis 
of CBT for internalizing disorders in children and adolescents in routine 
clinical care, Wergeland, Riise and Öst (2021) reported treatment out-
comes in routine clinical care comparable to those in university settings. 
To better understand how CBT-oriented treatments for externalizing 
disorders work in clinical practice, it is important to evaluate how 
evidence-based treatment programs perform in real world settings. 
During the last 10 years a substantial number of effectiveness studies in 
non-university settings have been published, and findings from such 
studies provide important information to clinicians and decision makers 
as to whether empirically supported treatments can be expected to yield 
the intended results when implemented in routine clinical care. Despite 
the importance of effectiveness studies for dissemination of empirically 
validated treatments, systematic reviews of treatments for externalizing 
disorders in routine clinical care are scarce. Several systematic reviews 
of psychological treatment have been performed in the past decade for 
ADHD and CD/ODD respectively, but have not focused on effectiveness 
studies specifically (Bakker, Greven, Buitelaar, & Glennon, 2017; Burkey 
et al., 2018; Fabiano, Schatz, Aloe, Chacko, & Chronis-Tuscano, 2015; 
Kaminski & Claussen, 2017; Schatz et al., 2020; Sibley, Kuriyan, Evans, 
Waxmonsky, & Smith, 2014; Sonuga-Barke et al., 2013). Lee, Horvath, 
and Hunsley (2013) carried out a review of effectiveness studies of child 
therapy and reported an increased number of effectiveness studies from 
2007, high completion rates, and maintenance of treatment gains in 
follow-up assessments. They also found encouraging evidence for the 
effectiveness of parent training for disruptive behavior problems in 
routine clinical practice. Although a variability in treatment outcome 
data was found, the authors concluded that positive results could be 
obtained in various treatment settings with children presenting with 
multiple problems (Lee et al., 2013). This review was, however, limited 
to 13 studies of parent training which did not report inclusion criteria, 
making it difficult to ascertain whether the results apply to specific 
disorders such as ADHD, CD or ODD. Therefore, further assessment of 
effectiveness studies seems called for and a meta-analysis of the effec-
tiveness of CBT in the treatment of externalizing disorders in routine 
clinical care is warranted. 
The present meta-analysis is the first to review effectiveness studies 
of CBT and behavior therapy (BT) for ADHD, CD and ODD in children 
and adolescents. The included studies investigated the effect of empir-
ically supported treatment programs delivered by practising clinicians 
in non-university settings to patients referred for treatment through 
usual clinical routes (i.e. not actively recruited to a research project). 
The aims of the present meta-analysis are:  
1. To evaluate the effectiveness of CBT for children and adolescents 
with ADHD, CD and ODD in routine clinical care.  
2. To investigate moderators of treatment outcome in effectiveness 
studies.  
3. To investigate whether there are differences between effectiveness 
and efficacy studies in terms of background data or treatment data.  
4. To evaluate whether there are differences in the effect of CBT for 
externalizing disorders between effectiveness and efficacy studies. 
1. Method 
The protocol for this meta-analysis was pre-registered at PROSPERO 
with ID CRD42020147524. The meta-analysis was conducted according 
to the PRISMA guidelines (Liberati et al., 2009), and reported according 
to AMSTAR 2 (Shea et al., 2017), see online Supplement S7 and S8. Two 
independent raters were involved during each step of the study, except 
for the screening of title and abstract conducted by one rater only. 
The meta-analysis was designed according to the PICOS acronym in 
the following way:  
• Population: children and adolescents with ADHD, ODD and/or CD  
• Intervention: CBT or BT delivered in routine clinical care  
• Comparison: within-group change. i.e. pre vs. post-data  
• Outcome: primary continuous measure and remission  
• Study design: RCTs and open trials 
1.1. Literature search 
Studies were identified by a systematic and comprehensive literature 
search of electronic databases and scanning reference lists of articles. 
The search was applied to Ovid MEDLINE, Embase OVID, and PsycINFO 
from the start of the data bases to June 11th 2019. An updated search 
was done May 5th 2020. The list of search terms utilized to identify 
potential studies were generated by all four authors in collaboration 
with a university librarian, who conducted the database searches. We 
used the following search terms to search the databases: (Cognitive 
therapy OR behav* therapy OR cognitive behav* therapy OR anger 
management therapy OR exposure therapy) AND (attention deficit dis-
order OR attention deficit hyperactivity disorder (including the different 
subtypes) OR conduct disorder OR oppositional defiant disorder OR 
Hyperkinetic disorder OR Externali* disorder) AND (open study OR 
clinical study OR community trial OR intervention study OR Pre post 
study OR randomized controlled trial) AND (youth OR child* OR 
adolescent OR pediatric). For full search strategy for Ovid MEDLINE, 
Embase OVID and PsychINFO, see the online Supplement, S1. 
The first author read the titles and abstract of all the papers from this 
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initial search to decide whether a study warranted a more detailed 
reading. When there was an indication of a group of patients receiving 
the particular cognitive-behavioral treatment in a non-university setting 
the full-text was retrieved. The reference lists in the retrieved articles 
were then checked against the database search and any other articles 
that might fulfill the inclusion criteria were retrieved. Although research 
articles were the target of the search, review articles were also examined 
for additional references. Key authors were searched in databases to 
identify additional publications but were not contacted in personal 
communication. In total, 730 full-text articles were considered for in-
clusion. The final decision for article inclusion was made using a stricter 
set of inclusion and exclusion criteria detailed below. The full text ar-
ticles were read by different pairs of the authors and any disagreements 
were resolved by consensus discussion. It was determined that 51 arti-
cles could be included in the present meta-analysis. 
1.1.1. Inclusion criteria 
In order to be included in the review and meta-analysis a study had 
to:  
1. Be published, or in press, in an English language journal.  
2. Have participants diagnosed with ADHD, CD, or ODD according to 
DSM or ICD, or fulfilling a cut-off score on a validated parent or 
teacher rating scale.  
3. Be testing a form of CBT, cognitive therapy (CT) or behavior therapy 
(BT).  
4. Have participants referred for treatment through usual clinical 
routes.  
5. Be an effectiveness study, i.e. carried out in a non-university setting 
such as clinical routine care or school health care.  
6. Have therapists who are practicing clinicians for whom provision of 
service is a substantial part of the job (Shadish, Matt, Navarro, & 
Phillips, 2000).  
7. Have a treated sample consisting of at least 10 participants.  
8. Have a maximum participant age of 18.  
9. Provide a measure of the primary disorder treated. 
1.1.2. Exclusion criteria  
1. The study is a secondary analysis of a previously published study. 
2. The study is an evaluation of a service where the results for indi-
vidual disorders cannot be extracted.  
3. The study is not testing a form of CBT, CT, or BT.  
4. The study is testing a combination of CBT and pharmacological 
treatment. 
1.2. Cut-off scores for applied parent or teacher rating scales 
All ADHD- and 18 of 28 CD/ODD-studies used diagnosis as inclusion 
criterion, whereas 10 CD/ODD-studies used cut-off scores on the 
following parent or teacher rating scales: Child Behavior Checklist 
(CBCL; Achenbach, 1991), Eyberg Child Behavior Inventory (ECBI; 
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Fig. 1. Flowchart of the inclusion of studies.  
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Eyberg & Pincus, 1999), and Aversive Behavior Rate (ABR; Patterson, 
Chamberlain, & Reid, 1982). We transformed the various scores to 
percentiles and the five studies using CBCL had cut-off scores between 
84 and 95, the four studies using ECBI had scores between 90 and 95, 
and the single study applying the behavior observation instrument ABR 
used a score of 90. 
Fig. 1 shows a flowchart of the inclusion of studies in the present 
meta-analysis. For references to included studies, see online Supplement 
S2, and for references to studies excluded in the meta-analyses, see 
online Supplement S3. 
1.3. Potential categorical moderators 
In order to include any potential categorical or continuous moder-
ator in the analysis we required that at least 70% of the studies provided 
information on that variable. With lower proportions it is questionable if 
the information extracted is representative of the entire body of studies. 
1.3.1. Type of study and statistical analysis 
Type of study was either RCT (when a CBT-condition was compared 
with some kind of control condition) or open trial (when only a CBT- 
condition was used in the study). Statistical analysis was categorized 
as intent-to-treat (ITT) if all randomized participants were included in 
the statistical analysis or completers if dropouts were deleted. 
1.3.2. Type of treatment and conditions 
It was not possible to classify the many treatment methods used 
based on their names since some methods might have different names 
but only differ slightly from each other. Instead we categorized the 
target of treatment as: child, parent, or child and parent, and treatment 
format as: group, individual, or group and individual. 
1.3.3. Parental and teacher involvement 
Degree of parental involvement was classified as low if parents were 
not present during sessions but informed about the progress of therapy, 
moderate if parents were present during some therapy sessions full-time 
or only part-time of all sessions, and high if parents were present full- 
time during all therapy sessions. Teacher involvement was classified 
as yes or no. 
1.3.4. Therapist profession 
The profession that the majority of the therapists within a study 
belonged to was classified as clinical psychologist, social worker, or 
various professions. 
1.3.5. Continent 
The country in which the study was carried out was categorized as 
North America, South America, Europe, Asia, Australia, or Africa. 
A coding scheme and manual including the variables of interest were 
developed. The data extraction and categorizations were done inde-
pendently by the first and the third author and any disagreements were 
solved after consensus discussion. 
1.4. Potential continuous moderators 
The following continuous measures on which at least 70% of the 
studies provided information were used as potential moderators: num-
ber of participants in the study, percent declining participation in the 
study, percent attrition in the study, percent on drug treatment for the 
principal disorder, percent boys, mean age, pre-treatment severity 
(calculated as percentage of the maximum score of the rating scale 
applied), methodology score (see below), risk-of-bias score (see below), 
number of therapy sessions, and treatment intensity (hours/week). In 
addition, we also extracted information on a number of other variables, 
but these variables did not reach the 70% criterion. 
1.5. Methodological quality 
1.5.1. The Psychotherapy Outcome Study Methodology Rating Scale 
(POMRS) 
The scale consists of 22 items covering various important aspects of 
the methodology in psychotherapy outcome research (Öst, 2008). Each 
item is rated as 0 = poor, 1 = fair, and 2 = good, and each step has a 
verbal description of one or more sentences. The total score can vary 
from 0 to 44 points. Since all items were not applicable to all studies the 
total score was recalculated as a percentage of the maximum score 
possible for the individual study. The internal consistency of the scale 
was good with a McDonald’s ω of 0.80. The inter-rater reliability of the 
scale (between the second and the fourth author), based on 20% 
randomly selected and blindly rated studies was ICC(3,1) = 0.94 (95% 
CI 0.75–0.99), which according to Cicchetti (1994) is excellent. 
1.6. Risk-of-bias 
The Cochrane Collaboration tool for assessing risk-of-bias (Higgins, 
Altman, & Sterne, 2011) was used, and the following domains were 
rated: random sequence generation, allocation concealment, blinding of 
outcome assessment, incomplete outcome data, and selective reporting. 
Blinding of patients and therapists cannot be used in psychotherapy 
studies. A high risk-of-bias in a domain was given 1 point, an unclear risk 
0.5, and a low risk 0 point. Summarizing over the five domains the total 
score could vary between 0 and 5, with higher scores indicating higher 
risk-of-bias. Inter-rater reliability was assessed between the second and 
the fourth author based on 20% randomly selected and blindly rated 
studies. This yielded an intra-class correlation, ICC(3, 1) = 0.95 (95% CI 
0.76–0.99), which is also excellent. 
1.7. Effect size measures 
We extracted data on both primary and secondary measures in the 
studies. This was done independently by the third and the fourth au-
thors, and any discrepancies were discussed to reach consensus. Since 
some studies used proportion of remitted participants as their primary 
outcome measure, whereas other studies used a continuous rating scale 
we decided to include both in this meta-analysis. 
1.7.1. Remission 
Below follows a description of the criteria of remission used in the 
different studies. 
ADHD: 11 out of 23 studies (48%) provided data and in 9 it was that 
the child’s post- or follow-up score was within the normal range on the 
primary outcome measure, whereas in 2 it was loss of the principal 
diagnosis. 
CD/ODD: 12 out of 28 studies (43%) provided data and in 11 it was 
that the child’s post- or follow-up score was within the normal range on 
the primary outcome measure (for 2 of which Reliable Change Index 
must also be fulfilled), and in 1 it was loss of the principal diagnosis. 
1.7.2. Continuous rating scales 
When a study named its primary outcome measure among rating 
scales we used that. If none was pinpointed we selected measures ac-
cording to the following hierarchy: independent assessor or observer 
rating, teacher report scale, parent report scale, and child self-report 
scale. All but one of the ADHD-studies and all CD/ODD studies pro-
vided data on a continuous rating scale. The various rating scales used 
for the respective studies are described in the online Supplement S4. 
1.7.3. Secondary outcome measures 
Besides symptom measures we also aimed to extract data on func-
tioning, broadly defined. However, only 7 out of 23 (30%) ADHD- 
studies and 10 out of 28 (36%) CD/ODD-studies had used such mea-
sures. With these low proportions of studies providing the relevant data 
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it is questionable if the outcome of a meta-analysis would be represen-
tative so we decided not to carry out one. 
1.8. Meta-analysis 
In order to obtain as large as possible a body of effectiveness studies 
we included both RCTs and open trials in the meta-analysis since within- 
group ES can be calculated from both types of studies. Within-group ES 
was calculated as (Mpre – Mpost)/SDpre according to recommendation by 
Lakens (2013), since there is good reason to assume that the in-
terventions influence not only the means but also the standard de-
viations. The mean ES was computed by weighting each ES by the 
inverse of its variance. Rate of remission, with event rate as the effect 
measure, was analyzed using mixed effect analysis in the subgroup 
analysis. In this analysis a random effects model is used to combine 
studies within each subgroup and a fixed effects model is used to 
compare subgroups and yield the overall effect. When a study presented 
intent-to-treat data (49%) these were used, if not completer data (51%) 
were used. 
Before pooling the effect sizes we screened for statistical outliers, 
defined as being outside M ± 2SD. At the post-treatment assessment four 
(2.2%) of the ESs were outliers, and at follow-up assessment there was 
one (2.3%). For these ESs winsorising (Lipsey & Wilson, 2001) was used 
by reducing outliers to the exact value of M + 2SD. The software 
Comprehensive Meta-Analysis v.3 (CMA; Borenstein, Hedges, Higgins, & 
Rothstein, 2013) was used for all analyses and to correct for small 
sample sizes Hedges’s g was calculated. A random effects model was 
used since it cannot be assumed that the ESs come from the same 
population. 
Heterogeneity among ES’s was assessed with the Q- and the I-square 
statistic. The possibility of publication bias was analyzed with the trim- 
and-fill method of Duval and Tweedie (2000) as well as Egger’s 
regression intercept (Egger, Smith, Schneider, & Minder, 1997). 
Moderator analyses of continuous variables were carried out with meta- 
regression and for categorical variables with subgroup analysis using the 
mixed effect model. 
1.9. Efficacy studies for comparison 
In order to obtain the efficacy studies to be used in comparison of the 
effect of CBT in effectiveness studies we consulted the most recent evi-
dence base update reviews of psychosocial treatments published in the 
Journal of Clinical Child and Adolescent Psychology for the respective 
disorders included in the present meta-analysis. For ADHD it was Evans 
et al. (2014); Evans, Owens, Wymbs, and Ray (2018), and for CD/ODD 
McCart and Sheidow (2016) and Kaminski and Claussen (2017). In some 
of these reviews the authors referred to earlier reviews, which we 
checked in order to get as comprehensive as possible a list of efficacy 
RCTs. From each of these reviews we listed the RCTs of some kind of 
cognitive behavioral treatment evaluated as well-established or prob-
ably efficacious according to the criteria adopted by the Society of 
Clinical Child and Adolescent Psychology (Southam-Gerow & Prinstein, 
2014). Then we deleted those RCTs we had already included in the body 
of effectiveness studies. This resulted in the following number of efficacy 
RCTs for our comparison: ADHD 29 and CD/ODD 33, for a total of 62 
trials. These references are listed in the online Supplement S5. 
As for the effectiveness studies we extracted data for the primary 
continuous outcome measure and remission rate, separately at post- 
treatment and follow-up assessment. In order to compare the two cate-
gories of studies on background variables we also extracted data on 
mean age, proportion of boys, percent with comorbid disorders, pro-
portion on medication for the principal disorders, pre-treatment severity 
(calculated as percent of maximum score on the continuous measure), 
treatment time (60 min. hours), and attrition. Other variables were not 
reported systematically, or not at all in a large enough proportion of 
studies, which precluded inclusion as a background variable. 
1.9.1. Power analysis 
In the overall comparison of effectiveness and efficacy studies we 
have the following number of studies and treatment conditions, which is 
the unit of analysis: effectiveness studies ADHD 23/28, CD/ODD 28/39 
for a total of 51/67; efficacy studies ADHD 29/43, CD/ODD 33/62 for a 
total of 62/105. The total number is then 113 studies with 172 condi-
tions with an average of 46 participants per condition. According to the 
formulas for power analysis in meta-analyses by Valentine, Pigott, and 
Rothstein (2010) we would have 100% power to detect an effect size of 
0.20 and 88% for an ES of 0.10, when assuming that the heterogeneity of 
effect sizes will be high. 
2. Results 
2.1. Description of the studies 
2.1.1. Study characteristics 
Background data for the included studies are presented in Table 1. 
The majority of the 51 studies were done in North America (n = 25) and 
Europe (n = 23), whereas only 3 came from Australia, and none from 
Africa, Asia, or South America. The total number of participants in these 
studies was 5295 with 3798 in CBT-conditions, 298 in other treatments, 
e.g. pharmacological, and 1199 in control conditions. For ADHD it was 
2223 in 23 studies (1675 in CBT-conditions and 548 in control condi-
tions) and for CD/ODD 2774 in 28 studies (2123 in CBT-conditions and 
651 in control conditions). The proportion of eligible participants that 
declined the offer of treatment was on average 12.7% (ADHD 10% and 
CD/ODD 15%). 
There was an overall majority of boys (77.7%), both in ADHD 
(78.0%) and CD/ODD (77.3%). The mean age across all studies was 8.2 
years (ADHD 8.7 and CD/ODD 7.9). Proportion of participants with 
comorbidity was reported by only 24 studies (47%), and in an unsys-
tematic fashion. With that in mind, 52.9% of the participants had at least 
one comorbid disorder (46.7% in ADHD and 63.2% in CD/ODD). Only 
33 studies (66.7%) reported what proportion of the participants was on 
psychotropic medication for their principal disorder at the inclusion to 
the respective study. The overall mean was 32.5% with a significant 
difference (t(32) = 2.38, p = 0.024) between ADHD (41.6%) and CD/ 
ODD (19.5%), which would be expected since central stimulants are 
evidence based for ADHD. 
2.1.2. Treatment data 
Treatment data for the included studies are presented in Table 2. The 
target of treatment was the parent in 25 (49.0%), parent and child in 21 
(41.2%), and child only in 5 studies (9.8%). The format of treatment was 
group in 25 (49.0%), individual in 22 (43.1%), and the combination of 
group and individual treatment in 4 studies (7.8%). The number of 
therapists per study was on average 11.1 (range 1–56), which indicates 
the number of participating therapists working at the routine clinical 
sites where the studies were done. Treatments were carried out over 
15.0 weeks on average (12.0 for ADHD and 17.5 for CD/ODD) and the 
mean number of sessions was 17.3 (ADHD 17.5, CD/ODD 17.2). The 
intensity (hours/week) was on average 2.8 (ADHD 3.9, CD/ODD 1.8). 
2.2. Methodological data 
2.2.1. Methodology ratings 
The research methodology score (% of maximum possible score for 
the individual study) had an overall mean of 47.4 (SD 12.3), which 
corresponds to a raw score of 20.9 points. The mean for ADHD-studies 
was 46.9 (SD 14.3) and for CD/ODD studies 47.7 (SD 10.8), a non- 
significant difference (t(65) = 0.26, p = 0.80). As could be expected 
the RCTs (M 50.8, SD 11.2) across the two disorders had a significantly 
higher methodology score (t(65) = 4.44, p < 0.001) than did the open 
trials (M 37.3, SD 9.5). 
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2.2.2. Risk of bias 
The risk of bias categorization is presented in the online Supplement, 
Table 6. If we delete the 16 open trials from the evaluation of the first 
two domains we find the following proportions of a low risk-of-bias: 
Random sequence 83%, allocation concealment 46%, blinding of as-
sessors 29%, incomplete data 59%, and selective reporting 84%. A high 
risk-of-bias was found in: random sequence 6%, allocation concealment 
9%, blinding of assessors 51%, incomplete data 35%, and selective 
reporting 0%. Thus, it was much more common that these studies had a 
low than a high risk-of-bias regarding the evaluated domains. 
In order to score the risk-of-bias a low risk was given 0, an unclear 
risk 0.5, and a high risk 1 point, which means that the total score could 
vary from 0 to 5 points. The total mean score was 1.87 (SD 1.52) and the 
studies within each disorder had the following mean (SD): ADHD 2.11 
(1.67) and CD/ODD 1.69 (1.41), a non-significant difference (t(65) =
1.10). As was found for methodological quality the RCTs (M 1.23, SD 
1.15) had a significantly lower risk-of-bias (t(65) = 8.38, p < 0.001) than 
the open trials (M 3.74, SD 0.75). 
2.3. Meta-analysis 
2.3.1. Attrition 
Forty-seven of the studies (92.2%) provided information on the 
number of participants who dropped out of the treatments. Using 
treatment condition (k = 63) as the unit of analysis the overall attrition 
rate was 14.4% (95% CI 11.5–18.0, z = 13.36, p < 0.0001). ADHD- 
studies (k = 27) had a dropout rate of 12.0% and CD/ODD-studies (k 
= 36) 16.4%, which was not a significant difference (Qbetween (1 df) =
Table 1 
Background data of the included studies.  
Study Continent Type of study Analysis Methodology Severity % Comorb. % Decliners N % Males Age range Mean age % on meds 
ADHD             
Abikoff, 2015 North America RCT ITT  0.682  0.752  41.5  0  164  73.8  3–4  3.6  0 
Boyer, 2015 Europe RCT ITT  0.682  0.474  31.4  0.6  159  73.5  12–17  14.4  78.0 
Breider, 2019 Europe RCT ITT  0.455  0.323  76.2  29.0  21  71.4  4–12  7.8   
Canu, 2011 North America Open trial ITT  0.325  0.719  100  0  16  88  4–12  8.0   
Curtis, 2010; 2013 North America Open trial ITT  0.250  0.744    22.0  21  71  7–10  7.8  64.0 
Daley, 2013 Europe RCT ITT  0.618  0.783    7.1  43  81.4  4–11  7.3  0 
Döpfner, 2004 Europe RCT Compl.  0.455  0.600  61.3    75  93.3  6–10  8.3  0 
Elkins, 2019 North America Open trial Compl.  0.350  0.770  52.0    67  76.0  7–10  8.0  72.0 
Fehlings, 1991 North America RCT ITT  0.523  0.563  0    25  100  7–13  9.5  0 
Hannesdottir, 2017 Europe Open trial ITT  0.341  0.684      41  70.7  8–10  9.2  78.0 
Heath, 2015 North America Open trial Compl.  0.375  0.740      47  79.1  7–12  8.0  74.4 
Jerrott, 2010 North America Open trial Compl.  0.310  0.693  72.5    57  84.2  5–13  10.4  78.0 
Loren. 2015 North America Open trial Compl.  0.425    27.6    241  75.6  6–12  8.6   
MTA-Group. 1999 North America RCT Compl.  0.738  0.467  39.9  4.4  579  80.3  7–9.9  8.5  30.7 
Ostberg. 2012 Europe RCT Compl.  0.310  0.200  4.3  9.8  92  83.6  7–10  10.9  80.3 
Pfiffner. 2013 North America Open trial Compl.  0.475  0.600    3.2  57  70.2  7–11  8.1  7.0 
Pfiffner. 2016; 2018 North America RCT ITT  0.477  0.626  50.4  10.0  135  71  7–11  8.4  8.9 
Power. 2012 North America RCT ITT  0.500  0.467  27.0  23.0  199  68.3  7–12  9.5  43.0 
Power. 2014 North America Open trial Compl.  0.500  0.667  36.0  28.0  72  69.4  5–10  7.0  34.7 
Sibley. 2018 North America RCT Compl.  0.571  0.467    21.8  218  74.2  12–15  13.5  45.9 
Tynan. 1999 North America Open trial Compl.  0.325  0.607    9.7  65  76.4  5–11  7.5  44.0 
Tynan 2004 North America Open trial ITT  0.250  0.641    9.5  67  82.4  5–11  7.9  43.1 
van den Hoofdakker. 2007 Europe RCT Compl.  0.477  0.933  80.9  2.0  96  80.9  4–12  7.4  50.0 
CD/ODD             
Axberg. 2012 Europe RCT ITT  0.524  0.635    6.1  62  83.9  4–8  6.0   
Axelrad. 2009 North America Open trial Compl.  0.425  0.670    0  64  84.0  2–6  4.7  1.6 
Bjorseth. 2016 Europe RCT ITT  0.591  0.587  74.6  11.0  81  70.4  2–7  5.8  12.3 
Burke. 2015 North America RCT ITT  0.429  0.753    22.0  252  100    8.9  7.5 
Chacko. 2015 North America RCT ITT  0.409  0.620      320  67.8  7–11  8.9  33.4 
Connolly. 2001 Europe RCT Compl.  0.273  0.642      129  86.8  2–9  6.2  2.3 
Costin. 2007 Australia Open trial Compl.  0.400  0.662  76.4    112  80.9  5–13  9.1   
David. 2014 Europe RCT Compl.  0.333  0.601    11.0  130  48.5  4–12  6.2 0 
Gardner. 2006 Europe RCT ITT  0.575  0.606    28.1  76  73.7  2–9  5.9   
Gavita. 2012 Europe RCT ITT  0.425  0.766    14.2  97    5–18  9.5   
Goertz-Dorten. 2019 Europe RCT ITT  0.545  0.567    36.4  101  100  6–12  8.7  14.3 
Greene. 2004 North America RCT Compl.  0.477  0.576  66.0  36.4  50  68.1  4–12  7.2  59.6 
Hansson. 2012 Europe RCT Compl.  0.357  0.626    0  46  60.9  2–17  15.0   
Harrington. 2000 Europe RCT ITT  0.568  0.698    25.0  141  79.0  3–10  6.9   
Helander. 2018 Europe RCT ITT  0.568  0.705  67.0  11.7  120  73.0  8–12  9.3   
Hutchings. 2002 Europe RCT ITT  0.429  0.696    10.6  41  85.4  2–10  6.0   
Kolko. 2009 North America RCT ITT  0.705  0.773  76.3  6.8  139  84.9  6–11  8.8  51.1 
Larsson. 2009 Europe RCT ITT  0.568  0.623  35.4  8.0  136  79.5  4–8  6.6   
Lees. 2019 Australia RCT Compl.  0.476  0.539    10.6  126  68.3  3–7  5.4   
McGilloway. 2012 Europe RCT Compl.  0.525  0.621    4.0  149  62.8  2–7  4.8   
McNeil. 1991 North America Open trial ITT  0.625  0.717  90.0    12  100  2–7  4.5  0 
Nixon. 2003 Australia RCT ITT  0.523  0.661      63  70.4  3–5  3.9  0 
Patterson. 1982 North America RCT Compl.  0.405      34.5  19  68.4  3–11  6.8   
van de Wiel. 2007 Europe RCT Compl.  0.455  0.746  62.5    77  88.3  8–13  10.0  40.3 
van Manen. 2004 Europe RCT ITT  0.523  0.668      97  100  9–13  11.0   
Westermark. 2011 Europe RCT ITT  0.405  0.696    7.9  35  51.4  2–18  15.0   
Woltering. 2011 North America Open trial ITT  0.342  0.325  21.0    71  72.0  8–12  9.5  25.4 
Woltering. 2015 North America Open trial Compl.  0.289  0.721      39  79.5  8–12  9.5  25.6 
Note: RCT = randomized controlled trial, ITT = intent-to-treat, Compl. = completers, Blank fields = data not provided, Severity = percentage of the maximum score on 
the primary outcome measure, % Comorb. = proportion having any psychiatric comorbid disorder, % Decliners = proportion of participants who were offered 
treatment in the study but declined (irrespective of reason), % on meds. = proportion on any psychotropic medication. 
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1.72, p = 0.19). 
2.3.2. Primary continuous measure 
Table 3 displays the mean effect sizes of the primary continuous 
measure for all studies at post-treatment and follow-up assessment, 
which was done on average 10.8 months after the end of therapy. At 
post-treatment the average ES was large (g = 0.91) and significantly 
different from zero. Heterogeneity was significant and large as indicated 
by the Q- and I2-values. CD/ODD-studies (g = 0.98) had a somewhat 
higher ES than ADHD-studies (g = 0.80) but the difference was not 
significant. 
At follow-up the mean ES (g = 1.01) was insignificantly higher than 
at post-treatment (Qbetween (1 df) = 0.75, p = 0.39), but also significantly 
heterogeneous. The comparison between disorders was still not signifi-
cant. Thus, the treatment effects seen at post-assessment were main-
tained at follow-up. 
Publication Bias. The possibility of publication bias was investigated, 
using Duval and Tweedie’s trim-and-fill method and Eggers regression 
intercept. Regarding the post-treatment data the trim-and-fill method 
suggested trimming 17 conditions to the left of the mean which would 
lower the ES from 0.91 to 0.72 (95% CI 0.66–0.75). The regression 
intercept had a significant t(60) = 4.66, p < 0.01, indicating that pub-
lication bias probably is an issue for this body of studies. 
2.3.3. Remission 
The remission rates at post-treatment and follow-up are presented in 
Table 4. At post-treatment 43.8% of the participants had remitted, 
which was significantly heterogeneous. A subgroup analysis indicated 
that CD/ODD-studies had about 10 percentage points higher remission 
rate than ADHD-studies but the difference was not significant. 
At follow-up assessment the overall remission rate had increased to 
51.4% but the difference to the post-assessment rate was not significant 
(Qbetween (1 df) = 1.38, p = 0.24). The subgroup analysis also showed 
that the disorders did not differ significantly from each other. Thus, as 
was the case for continuous measures the effect sizes seen at post- 
assessment were maintained at follow-up. 
Publication Bias. Eggers regression intercept did not yield a signifi-
cant t-value (1.15, p = 0.26). The trim-and-fill method suggested trim-
ming 7 studies, which would have reduced the remission rate from 
43.8% to 37.4% (95% CI 30.6–44.8). Thus, publication bias does not 
seem to be an important problem regarding the remission rate. 
2.3.4. Moderator analyses 
As the mean ES was significantly heterogeneous we followed up with 
moderator analyses. Table 5 shows the results for categorical variables 
using subgroup analysis with the results for effect size in the left column 
and remission rate in the right. There was no significant difference be-
tween RCTs and open trials. Regarding statistical analysis studies with 
intent-to-treat analysis yielded non-significantly lower ES than studies 
using completer analysis. There was no significant differences depend-
ing on target or format of therapy, degree of parental involvement, 
teacher involvement or therapist profession. The continent at which the 
study was carried out was associated with a significant difference; 
studies from Australia had the highest ES. However, since the ES for 
Australia is made up of only 5 conditions this difference should be 
interpreted with caution. 
Continuous variables on which at least 70% of the studies provided 
information were analyzed with the meta-regression module in the CMA 
program using the fixed effects analysis (see Table 6). Since 11 variables 
were included we used the Holm-Bonferroni correction (see Jaccard & 
Guilamo-Ramos, 2002). For effect size there were four negative mod-
erators: mean age of the participants in the condition, proportion of 
participants on drug treatment for the principal disorder, percent attri-
tion, and risk-of-bias, i.e. the higher the values on these moderators the 
lower the ES. There was one positive moderator, pre-treatment severity, 
i.e. higher severity was associated with higher ES. For remission rate 
there were three negative moderators: mean age, percent on drug 
treatment, and attrition rate. In addition, there was one positive 
moderator: number of sessions, i.e. higher number of sessions was 
associated with higher remission rate. 
2.4. Efficacy-effectiveness comparison 
In the following section (Tables 7-10) we compare data for the 
effectiveness studies reviewed so far with data for the efficacy studies 
obtained from the evidence base update reviews on ADHD and CD/ODD 
published in the Journal of Clinical Child and Adolescent Psychology. 
2.4.1. Background and treatment variables 
Table 7 presents a comparison between efficacy and effectiveness 
studies on some background variables and one treatment variable. Since 
there are 7 variables and 14 t-tests the Holm-Bonferroni correction was 
used. The only significant difference emerged on percent comorbidity 
for the CD/ODD studies where effectiveness studies had a higher pro-
portion than efficacy studies. However, this result must be treated with 
caution since only 43.8% of the effectiveness and 46.7% of the efficacy 
studies provided data on this variable. There were no significant dif-
ference between the two types of studies regarding mean age, proportion 
of participants on medication for the principal disorder, and percent 
attrition. If we use a p-value of 0.05 effectiveness studies had higher 
proportion of boys in both disorders. a higher pre-treatment severity in 
CD/ODD, and a lower treatment time in ADHD-studies, but these dif-
ferences can only be regarded as trends since they don’t fulfill the Holm- 
Bonferroni correction criterion. Thus, judging from the background 
treatment variables which could be extracted the effectiveness studies 
do not consist of participants who are easier to treat than do the efficacy 
studies. 
2.4.2. Effect size on primary outcome measure 
Table 8 presents the subgroup analyses comparing the within-group 
effect size (Hedges’ g) for effectiveness and efficacy studies within each 
disorder. Neither at post-treatment assessment (upper part) nor at 
follow-up (lower part) were there any significant differences between 
the two types of studies. For both types the ESs were significant and the 
effects were maintained, or somewhat higher, at follow-up, which was 
done on average 9.9 months after post-assessment for ADHD- and 11.3 
months for CD/ODD-studies (t(63) = 0.45, p = 0.66). 
2.4.3. Remission 
Table 9 contains subgroup analyses comparing the remission rates at 
post-treatment and follow-up assessment. Neither the post-treatment 
(upper part of Table 9) nor the follow-up (lower part) remission rates 
differed between study types for ADHD or CD/ODD. When combining 
the remission rates for the different disorders the post-treatment means 
were 43.8% and 46.1% for effectiveness and efficacy studies, respec-
tively. The corresponding follow-up means were 51.4% and 53.7%, 
which means that the increase from post- to follow-up assessment was 
7.6 percentage points for both categories of studies. 
2.4.4. Comparison of RCTs only 
Since the outcomes presented in Tables 8 and 9 might have been 
unduly influenced by open trials we repeated the analyses using only 
RCT effectiveness studies. Table 10 summarizes the results across dis-
orders and there were no significant differences between effectiveness 
and efficacy studies regarding effect size or remission rates at post- 
treatment or follow-up assessment. 
3. Discussion 
The primary aim of the present meta-analysis was to investigate the 
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Table 2 
Treatment data of the included studies.  
















ADHD             
Abikoff. 2015 New Forrest Parenting Package 
(NFPP) 
PBT (with 
child) + TI 
Psychologist P I Y High N  8  1  9.0  6  




Psychologist P I Y High N  8  1  6.3  6 
Boyer, 2015 Plan my Life (PML) TI Psychologist C I N Moderate N  10  1.1  4.8  3  
Solution focused therapy (SFT) TI Psychologist C I N Low N  10  1.1  5.3  3 
Breider, 2019 Blended parent training PBT Psychologist P G Y High N  16  0.9  90.9  0  
Face-to-face parent training PBT Psychologist P I Y High N  4  1  40.0  0 
Canu, 2011 Defiant children PBT Psychologist P G Y High N  6  1.5  0  0 
Curtis, 2010; 2013 Family Stars PBT + ChBT Various C, P I Y Moderate N  10  1  0  0 
Daley, 2013 New Forest Parenting Package 
Self-help 
PBT NA (Self- 
help) 
P I Y High N  1  0.3  12.5  0 
Döpfner, 2004 Behavior therapy +
Psychoeducation 
PBT + ChBT 
+ TT  
C, P I Y Moderate Y  18  3  2.9  0 
Elkins, 2019 Family Stars PBT + ChBT  C, P I Y Moderate N  10  1  17.9  0 
Fehlings, 1991 CBT ChBT  C I N Moderate N  20  1.8  0  5 
Hannesdottir, 2017 OutSMART ChBT + TI Psychologist C G N Low N  10  4  6.3  3  
Parent training program PBT Psychologist P G Y High N  7  2  18.2  3 
Heath, 2015 Family Stars PBT + ChBT Psychologist C, P I Y Moderate N  10  1  8.5  0 
Jerrott, 2010 CBT PBT + ChBT Various C, P G Y Moderate Y  32  2    39 
Loren, 2015 Parent group program PBT Psychologist P G Y High N  8  2  31.5  0 
MTA-Group, 1999 Behavioral treatment PBT + ChBT 
+ TT  
C, P G, I Y Moderate Y  91  6.9  2.1  82 
Ostberg, 2012 Strategies in Everyday Life (SEL) PBT + TT  P G Y Moderate Y  18  2.8  16.7  3 
Pfiffner, 2013 Collaborative Life Skills Program 
(CLS) 
PBT + ChBT 
+ TT 
Various C, P G Y Moderate Y  22  1.5  5.0  0 
Pfiffner, 2016; 
2018 
Collaborative Life Skills Program 
(CLS) 
PBT + ChBT 
+ TT 
Various C, P G Y Moderate Y  23  1.5  0  7 
Power, 2012 Family School Success (FSS) PBT + ChBT 
+ TT 
Psychologist P G, I Y Moderate Y  12  1.3  4.3  3 
Power, 2014 Partnering to Achieve School 
Success (PASS) 
PBT + TT Psychologist P I Y High Y  9  0.5  24.0  0 
Sibley, 2018 High Intensity skills-based 
summer intervention 
PBT + ChBT Various C, P G Y Moderate N  40  45    8  
Low Intensity skills-based 
summer intervention 
PBT + ChBT Various C, P G Y Moderate N  8  1.5    8 
Tynan, 1999 Parent training and child social- 
skills training 
PBT + ChBT  C, P G Y Moderate N  8  2  15.4  0 
Tynan 2004 Parent training and child social- 
skills training 




Behavioral parent training PBT Psychologist P G Y High N  12  1.2  12.5  6 
CD/ODD                 
Axelrad, 2009 Brief Behavioral Intervention 
(BBI) 
PBT  P I Y High N  5  0.83  14.1  12 




Psychologist P I Y High N  21.1  1  12.5  12 
Burke, 2015 Stop Now And Plan (SNAP) PBT + ChBT  C, P G, I Y Moderate N  24  2    12 
Chacko, 2015 Multiple Family Group (MFG) PBT (with 
child) + FI 
Various C, P G Y High N  16  1.8  34.2  12 
Connolly, 2001 Incredible Years (IY) PBT  P G Y High N  12  1.8  50.0  6  
Incredible Years (IY) + Child 
Intervention 
PBT  P G Y Moderate N  12  1.8  45.1  6 
Costin, 2007 Skilled Parenting Program PBT  P G Y High N  8  2  5.3  5 
David, 2014 Rationale Positive Parenting 
Program 
PBT Various P G Y High N  10  1.5  20.0  1  
CBT Standard PBT Various P G Y High N  10  1.5  14.9  1 
Gardner, 2006 Incredible Years (IY) PBT Various P G Y High N  14  2  11.6  12 
Gavita, 2012 Short cognitive-behavioral group 
parenting program 
PBT  P G Y High N  4  1.3  21.4  3 
Goertz-Dorten, 
2019 
Treatm. Progr. for Children with 
Aggr. Beh. (THAV) 
ChBT Psychologist C I N Low N  24  0.8  0  0 
Greene, 2004 Collaborative Problem Solving 
(CPS) 
PBT Psychologist P I Y High N  11  1  6.7  4  
Parent Training (PT) PBT Psychologist P I Y High N  10  1  5.0  4 
Hansson, 2012 Multidimensional Treatment 
Foster Care (MTFC) 
MCT Various C, P I Y Moderate Y      15.8  12 
Harrington, 2000 Parent training – community PBT  P G Y High N      48.6  9  
Parent training – hospital PBT  P G Y High N      40.6  9 
Helander, 2018 KOMET PBT Psychologist P G Y High N  11  2.5  8.0  0  
PBT + ChBT Psychologist P G Y Moderate N  26  4.3  17.2  0 
(continued on next page) 
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effectiveness of CBT for ADHD, CD and ODD for children and adoles-
cents in routine clinical care. The overall within-group effect size across 
the disorders was large and statistically significant, thereby demon-
strating that the treatments are effective in real-world settings. The re-
sults showed that 44% of children and adolescents with externalizing 
disorders achieved remission after treatment in routine clinical care and 
that more than half of the participants were remitted at follow-up. 
Furthermore, the results showed that 86% of the participants with 
externalizing disorders completed CBT. The completion rate is slightly 
higher than what was reported in a review of treatment effectiveness 
studies for psychological problems in children and adolescents (Lee 
et al., 2013), which found that 75% of participants completed parent 
training for disruptive disorders in real world settings. Lee et al. (2013) 
included 13 studies and reported significant effect sizes across studies 
for disruptive disorders, concluding that positive results from parent 
training can be obtained in a range of treatment settings. Our results 
extends the findings of Lee et al. (2013) by including 51 studies and 
providing meta-analytical evidence of treatment outcome as well as 
updated remission and attrition rates for CBT for child and adolescent 
externalizing disorders in routine care. The results are encouraging and 
suggest that CBT for externalizing disorders are effective in routine 
clinical care, acceptable to clinically referred participants, and that a 
majority of the patients achieves remission at follow-up. 
Regarding the magnitude of the effect size for ADHD (g = 0.80), our 
finding is similar to that of Fabiano et al. (2015) who conducted a sys-
tematic review of published meta-analyses on psychosocial treatments 
for ADHD. Of note, the meta-analyses were largely based on studies from 
university settings. Fabiano et al. (2015) concluded that the effect sizes 
across meta-analyses were generally moderate to large for behavioral 
outcomes. However, direct comparisons of effect size estimates to spe-
cific studies are not applicable since many previous meta-analyses have 
investigated subtypes of cognitive behavioral interventions including 
school-based treatments (DuPaul & Eckert, 1997; DuPaul, Eckert, & 
Vilardo, 2012) and parent training (Charach et al., 2013; Corcoran & 
Dattalo, 2006; Lee, Niew, Yang, Chen, & Lin, 2012; Zwi, Jones, Thor-
gaard, York, & Dennis, 2011). There are meta-analyses that have 
included a wider range of cognitive behavioral treatments for ADHD, 
but most of them have excluded open trials and reported between-group 
ES only (Klassen, Miller, Raina, Lee, & Olsen, 1999; Sonuga-Barke et al., 
2013; Van der Oord, Prins, Oosterlaan, & Emmelkamp, 2008) making 
comparisons to the current ES estimates difficult. However, a meta- 
analysis by Fabiano et al. (2009) was similar in study inclusion 
criteria and effect size calculation. That meta-analysis investigated the 
effect of a wide range of behavioral interventions for ADHD and 
included both RCTs and open trials. Unlike the present meta-analysis 
they included studies regardless of their status as efficacy or effective-
ness studies. Interestingly, they found a within-group effect size of 0.70, 
which is only slightly lower than the effect size for ADHD in the present 
study. 
Most meta-analyses on treatment of disruptive behavior disorders 
have also reported between-group ES only, typically demonstrating 
small to moderate effect sizes (Bakker et al., 2017; Erford, Paul, Oncken, 
Kress, & Erford, 2014; McCart, Priester, Davies, & Azen, 2006). How-
ever, two meta-analyses have investigated the effect of psychosocial 
treatments for conduct problems and included both RCTs and open trials 
and reported large within-group effect sizes of 0.95 (Fossum, Hande-
gård, Martinussen, & Mørch, 2008) and 1.05 (Fossum, Handegård, 
Adolfsen, Vis, & Wynn, 2016). Considering that these two meta-analyses 
included a large number of studies from research settings it is encour-
aging that the ES for CD/ODD in the present meta-analysis (g = 0.98) 
was similar to those reported by Fossum et al. (2016, 2008). Thus, the 
current results are congruent with previous meta analyses, which have 
Table 2 (continued ) 
















KOMET + The Coping Power 
Program 
Hutchings, 2002 Standard parent training PBT Various P I Y High N      31.6  0  
Intensive parent training PBT (with 
child) 
Psychologist P I Y High N      4.5  0 
Kolko, 2009 Modular treatment – community MCT (comm) Social 
worker 
P, C I Y Moderate Y  21.6  1.4  2.9  36  
Modular treatment – clinic MCT (clinic) Social 
worker 
P, C I Y Moderate Y  15.4  1.1  20.9  36 
Larsson, 2009 Incredible Years (IY) PBT Various P G Y High N  13  2  4.3  12  
IY + Dinosaur School Program PBT + ChBT Various P, C G Y Moderate N  31  3.4  0  12 
Lees, 2019 IY PBT Various P G Y High N  13  2  34.9  6  
IY + Home Parent Support (HPS) PBT (+ HPS) Various P G, I Y High N  23  2.8  17.5  6 
McGilloway, 2012 IY PBT Various P G Y High N  14  2  4.0  0 




Psychologist P I Y High N  14  1  0  18 
Nixon, 2003 PCIT standard PBT (with 
child) 
Psychologist P I Y High N  12  1.3  22.7  6  
PCIT abbreviated PBT (with 
child) 
Psychologist P I Y High N  10  0.9  13.0  6 




Various P I Y High N  17  1  0  0 
van de Wiel, 2007 Utrecht Coping Power Program 
(UCPP) 
PBT + ChBT Psychologist P, C G Y Moderate N  38  1  10.5  0 
van Manen, 2004 Social Cognitive Intervention 
Program (SCIP) 
ChBT Psychologist C G N Low N  11  1.2  0  12  
Social Skills Training Program 
(SST) 
ChBT Psychologist C G N Low N  11  1.2  0  12 
Westermark, 2011 Multidimensional Treatment 
Foster Care (MTFC) 
MCT Various P, C I Y Moderate Y  40  1  10.0  12 
Woltering, 2011 Stop Now And Plan (SNAP) PBT + ChBT Various C, P I Y Moderate N  14  3    0 
Woltering, 2015 Stop Now And Plan (SNAP) PBT + ChBT Various C, P I Y Moderate N  14  3    12 
Note: PBT = parent behavior therapy, TI = training intervention, ChBT = child behavior therapy, TT = teacher training, Tx target = target of treatment, C = child, P =
parent, Tx form. = treatment format, G = group, I = individual, PMT = parent management training, Y = yes, N = no, Parent involvem. = degree of parental 
involvement, % Attrition = proportion dropping out of those participating in at least one session, F-Up = follow up in months. 
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reported within-group ES, but slightly higher than previous meta ana-
lyses on disruptive behavior disorders which have only reported 
between-group ES. 
The fact that the effect size for CD/ODD (g = 0.98) was slightly 
higher than for ADHD (g = 0.80) is interesting. It can be argued that this 
finding is contrary to expectations, considering that the comprehensive 
review of meta-analyses for ADHD (Fabiano et al., 2015) reported 
moderate to large effect sizes for behavioral outcomes, whereas meta- 
analyses on disruptive behavior disorders have reported small to mod-
erate effect sizes. However, the findings from a meta-analysis of CBT for 
externalizing disorders (Battagliese et al., 2015) found a moderate and 
statistically significant effect size, and in accordance with our findings, 
they found better outcomes for CD and ODD than for ADHD, with large 
effect sizes for CD and ODD and moderate effect sizes for ADHD. 
Parents received treatment in 90% of the effectiveness studies; either 
as the only recipient (49%) or together with their child (41%). Parent 
management training is well-established as a stand-alone treatment for 
ADHD (Evans et al., 2018) and childhood disruptive behavior (Kaminski 
& Claussen, 2017) and as part of multicomponent treatments for ado-
lescents with disruptive behavior (McCart & Sheidow, 2016). Further-
more, some studies suggest that parenting behavior mediates the effect 
of parent training (Forehand, Lafko, Parent, & Burt, 2014). Accordingly, 
it might be expected that higher parental involvement would positively 
affect outcome. However, whether the treatment targeted parents, 
children or both, or the degree of parental involvement did not moderate 
effect size significantly. These results are in congruence with previous 
studies specifically assessing the potential effect of involving parents or 
children in treatment, which have typically not found significant effects 
(Corcoran & Dattalo, 2006; Lundahl, Risser, & Lovejoy, 2006; Thulin, 
Svirsky, Serlachius, Andersson, & Öst, 2014). It might be that the con-
tent of the parent intervention is of greater importance than the quan-
tity. For instance, Kaminski, Valle, Filene, and Boyle (2008) found that 
treatment programs with components that focused on increasing posi-
tive parent–child interactions and emotional communication skills, 
teaching parents to use time out and the importance of parenting con-
sistency, and requiring parents to practice new skills with their children 
during parent training sessions were associated with better outcomes. 
On the other hand, they found that treatments that focused on teaching 
parents problem solving, teaching parents to promote children’s 
Table 3 
Within-group effect size (Hedges’ g) for all studies (RCTs and open trials) divided by disorder with treatment condition as unit of analysis.  
Disorder k g 95% CI z-value Q-value p-value I2 
Post-treatment 
Both disorders  65  0.91  0.81–1.00  18.27a  208.96a    69.4 
ADHD  26  0.80  0.67–0.93  11.76a  3.50*  0.06   
CD-ODD  39  0.98  0.85–1.12  14.31a        
Follow-up 
Both disorders  45  1.01  0.87–1.14  15.00a  188.38a    76.6 
ADHD  14  0.88  0.70–1.07  9.52a  1.93*  0.17   
CD-ODD  31  1.06  1.89–1.24  11.87a      
Note: k = number of treatment conditions. a p < 0.0001. * Comparison between the disorders. 
Table 4 
Rates of remission for all studies divided by disorder.  
Disorder k % 95% CI z-value† Q-b p-value I2 
Post-treatment 
Both disorders  31  43.8  36.5–51.4  1.61  214.34a    86.0 
ADHD  12  37.7  26.7–50.2  1.93  1.51*  0.22   
CD-ODD  19  47.6  38.0–57.3  0.49        
Follow-up 
Both disorders  17  51.4  41.3–61.3  0.26  106.44a    85.0 
ADHD  5  38.2  21.8–57.9  1.18  2.68*  0.10   
CD-ODD  12  56.8  46.5–66.5  1.29       
Note: k = number of treatment conditions. a p < 0.0001. † Test if significantly different from 50%. * Comparison between the two disorders. 
Table 5 
Subgroup analysis of the effect size and remission for all studies at post- 
treatment.   
Effect size Remission 
Variable k g 95% CI k % 95% CI 
Type of study (Qb = 0.02, p = 0.90)* (Qb = 0.006, p = 0.94)* 
RCT  50  0.90  0.79–1.02  25  43.9  35.2–53.1 
Open Trial  15  0.92  0.77–1.06  6  43.5  35.7–51.5  
Statistical analysis (Qb = 1.15, p = 0.29)* (Qb = 3.07, p = 0.08)* 
Intent-to-treat  33  0.86  0.73–0.99  16  38.4  27.6–50.4 
Completers  32  0.97  0.82–1.12  15  50.2  44.6–55.8  
Target of treatment (Qb = 0.46, p = 0.80)* (Qb = 1.51, p = 0.47)* 
Child  7  0.82  0.56–1.09  5  32.4  11.5–63.9 
Parent  37  0.91  0.77–1.06  15  48.9  38.9–59.1 
Child and Parent  21  0.93  0.77–1.08  11  42.0  32.0–52.8  
Treatment format (Qb = 3.70, p = 0.16)* (Qb = 0.80, p = 0.37)* 
Group  32  0.81  0.68–0.94  19  44.9  36.6–53.6 
Individual  29  0.98  0.84–1.11  11  37.5  25.2–51.6 
Group + Individual  4  1.11  0.62–1.59  –      
Parental involvement (Qb = 1.25, p = 0.54)* (Qb = 0.24, p = 0.89)* 
Low  5  0.84  0.46–1.22  4  42.4  17.5–71.9 
Moderate  27  0.86  0.72–1.00  12  42.1  33.7–51.1 
High  33  0.97  0.82–1.12  15  45.9  34.0–58.2  
Teacher involvement (Qb = 0.52, p = 0.48)* (Qb = 0.88, p = 0.35)* 
Yes  12  0.84  0.62–1.05  7  48.2  42.0–54.5 
No  53  0.93  0.82–1.04  24  42.7  33.6–52.4  
Therapist profession (Qb = 2.51, p = 0.29)* (Qb = 1.74, p = 0.42)* 
Psychologist  25  0.90  0.74–1.07  9  37.2  21.2–56.5 
Social worker  7  0.79  0.55–1.03  6  50.6  43.9–57.2 
Various professions  16  1.06  0.83–1.30  7  52.4  30.0–73.8  
Continent (Qb = 6.77, p = 0.04)* (Qb = 2.36, p = 0.31)* 
Australia  5  1.37  0.99–1.75  4  59.9  37.6–78.8 
North America  28  0.91  0.77–1.05  11  42.7  32.0–54.3 
Europe  32  0.83  0.69–0.97  16  40.6  30.6–51.4 
Note: k = number of treatment conditions, Qb = Q between subgroups. * The 
statistic in parenthesis tests if the subgroups within the individual category differ 
significantly from each other. 
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Table 6 
Meta-regression analysis of the effect size and remission for all studies at post-treatment.   
Effect Size Remission 
Variable k Point z-value p-value k Point z-value p-value 
Mean age  65  − 0.053  − 5.53  0.00001*  31  − 0.173  − 6.10  0.00001* 
% drug treatment  40  − 0.006  − 4.84  0.00001*  19  − 0.018  − 6.64  0.00001* 
Attrition  59  − 0.010  − 4.91  0.00001*  30  − 0.027  − 6.72  0.00001* 
Pre-treatment severity  64  0.643  3.05  0.0023*  30  − 0.337  − 0.51  0.61 
Risk-of-bias  65  − 0.045  − 2.81  0.0047*  31  − 0.064  − 1.65  0.099 
Percent boys  64  0.007  2.81  0.0049  29  0.008  1.60  0.11 
Intensity of treatment  60  − 0.009  − 2.76  0.006  29  0.043  2.65  0.008 
# of sessions  60  0.004  2.71  0.007  29  0.026  3.10  0.002* 
1 outlier deleted  59  0.006  1.85  0.064  –       
Percent declining  47  − 0.007  − 2.26  0.024  23  0.065  0.64  0.52 
Methodology score  65  0.037  1.50  0.13  31  − 0.804  − 1.72  0.086 
# of participants  65  − 0.002  2.95  0.003  31  − 0.009  − 8.35  0.0001 
1 outlier deleted  64  − 0.000  − 0.11  0.91  30  − 0.014  − 3.34  0.008 
Note: k = number of treatment conditions, Point = point estimate. * Significant using the Holm-Bonferroni correction. 
Table 7 
Some background and treatment data (M and SD) for effectiveness and efficacy studies in the different disorders.  
Disorder k Age (years) % Boys % Comorb. % on meds. Severity % Attrition Tx time 
ADHD  p = 0.95 p = 0.05 p = 0.26 p = 0.96 p = 0.62 p = 0.28 p = 0.03 
Effectiveness 25 8.9 (2.6) 77.7 (7.7) 41.1 (25.8) 42.4 (31.8) 60.3 (16.2) 14.3 (18.9) 18.2 (8.4) 
Efficacy 43 8.9 (3.3) 73.0 (10.1) 49.6 (25.8) 42.0 (27.6) 58.5 (14.2) 10.2 (12.3) 23.5 (17.4)  
CD-ODD  p = 0.82 p = 0.03 p = 0.001 p = 0.10 p = 0.04 p = 0.15 p = 0.87 
Effectiveness 39 7.6 (2.6) 76.9 (14.2) 62.3 (19.9) 21.1 (22.4) 65.0 (8.2) 15.4 (14.5) 24.4 (13.7) 
Efficacy 62 7.5 (3.2) 70.2 (14.6) 18.0 (18.3) 11.7 (11.4) 60.6 (10.6) 11.4 (10.0) 23.7 (21.3) 
Note: k = number of treatment conditions, % Comorb. = proportion having any psychiatric comorbid disorder, % on meds. = proportion on any psychotropic 
medication, Severity = percentage of the maximum score on the primary outcome measure. % Attrition = proportion dropping out of those participating in at least one 
session. Tx time = number of 60 min therapy hours. 
Table 8 
Effect sizes (Hedges’ g) for effectiveness and efficacy studies within the different disorders.  
Disorder Study type k g 95% CI z-value Qb† p-value  
Post-treatment 
ADHD Effectiveness 26 0.80 0.67–0.93  11.76a    
Efficacy 40 0.74 0.61–0.87  11.05a 0.40 0.53 
CD-ODD Effectiveness 38 0.98 0.85–1.12  14.10a    
Efficacy 58 1.07 0.92–1.21  14.77a 0.65 0.42   
Follow-up 
ADHD Effectiveness 14 0.88 0.70–1.07  9.52a    
Efficacy 19 1.06 0.85–1.28  9.69a 1.51 0.22 
CD-ODD Effectiveness 30 1.06 0.88–1.24  11.58a    
Efficacy 38 1.10 0.94–1.26  13.79a 0.09 0.77 
Note: k = number of comparisons. a p < 0.0001. Qb = Q between, † Comparison Efficacy vs. Effectiveness within the respective disorders. 
Table 9 
Remission rates for effectiveness and efficacy studies for the different disorders.  
Disorder Study type k % 95% CI z-value* Qb† p-value  
Post-treatment 
ADHD Effectiveness  12 37.7 26.7–50.2 1.93    
Efficacy  17 33.4 23.2–45.4 2.67a 0.26 0.81 
CD-ODD Effectiveness  19 47.6 38.0–57.3 0.49    
Efficacy  23 54.8 48.1–61.4 1.40 1.43 0.23   
Follow-up 
ADHD Effectiveness  5 38.2 21.8–57.9 1.18    
Efficacy  2 44.3 36.5–52.7 1.37 0.33 0.57 
CD-ODD Effectiveness  12 56.8 46.5–66.5 1.29    
Efficacy  23 54.9 47.3–62.3 1.27 0.08 0.77 
Note: k = number of comparisons. a p < 0.01. * Test if significantly different from 50%. Qb = Q between, † Comparison Efficacy vs. Effectiveness within the respective 
disorders. 
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cognitive, academic, or social skills, and providing other, additional 
services were associated with smaller effect sizes. 
The majority of the included studies delivered the treatment in 
groups, but treatment format (i.e. individual, group or combined indi-
vidual and group treatment) or involving teachers in treatment did not 
significantly moderate the effect sizes. Although the involvement of 
teachers may be beneficial in certain cases, the results suggest that 
teacher involvement is not a crucial factor for treatment outcome in 
routine care, and that CBT for externalizing disorders is effective across 
different formats in routine care. The treatments had a mean number of 
17 sessions across a mean of 15 weeks, with a mean intensity of 
approximately three hours per week. There was no evidence that 
treatment intensity significantly moderated outcome; however, number 
of sessions positively affected treatment outcome, i.e. more sessions 
yielded higher effect sizes. Previous meta-analyses have demonstrated 
similar findings (Fossum et al., 2016; Shelleby & Kolko, 2015). 
Regarding patient characteristics, lower age was associated with a 
better outcome of treatment. It has been argued that externalizing 
problems become increasingly resistant to change with age (e.g. Ber-
nazzani, Côté, & Tremblay, 2001; Deković & Stoltz, 2015), and our re-
sults fit well with that assumption. Moreover, most of the studies in this 
meta-analysis involved parent behavior therapy, which is found to have 
a stronger effect on the youngest children (McCart et al., 2006). In line 
with these findings, a recent meta-analysis on psychosocial treatment for 
conduct disorder also found larger reductions in conduct problems in 
younger than in older children (Fossum et al., 2016). However, the 
literature is not consistent on this matter; two previous meta-analyses on 
parent training found no significant association between age and treat-
ment outcome (Cedar & Levant, 1990; Lundahl et al., 2006), whereas 
another found that older children benefitted more from behavioral 
parent training (Serketich & Dumas, 1996). Accordingly, no general 
conclusions can be drawn regarding the effect of age on treatment 
outcome. Nevertheless, the findings from the present meta-analysis 
suggest that, in routine care, younger age is associated with greater 
symptom reductions and higher remission rates after CBT. 
More severe symptoms at pre-treatment were associated with a 
larger effect size. This seems to be a common finding (e.g. Lundahl et al., 
2006) and a plausible reason is that it reflects that more severe cases 
have a larger room for improvement. This explanation is supported by 
the fact that remission rates were not associated with pre-treatment 
severity. The proportion of patients on psychotropic drugs at the 
beginning of treatment was a negative moderator of ES and remission 
rates. These two findings might seem somewhat contradictory, since it 
may be assumed that the samples with high pre-treatment severity 
would also have a high proportion of participants on psychotropic drugs. 
However, we did not include studies that investigated the effect of 
combination treatment. Hence, the participants were, as part of routine 
care, medicated if indicated and on a stable dose before starting CBT- 
treatment. Therefore, the participants who were already on psychotro-
pic drugs, may in fact have had less severe symptoms at pre-treatment, 
leaving a smaller room for improvement. It does not, however, explain 
why a higher proportion of patients on psychotropic drugs was associ-
ated with lower remission rates. The finding probably reflects that the 
ADHD studies had a significantly higher proportion of patients receiving 
medication while also yielding lower effect size and remission rates than 
CD/ODD studies (although not significantly lower). 
The most important and encouraging finding from the present meta- 
analysis was that the effectiveness-efficacy comparisons demonstrated 
no significant differences in ES between effectiveness and efficacy 
studies. The results are in line with a meta-analysis by Michelson, 
Davenport, Dretzke, Barlow, and Day (2013) investigating the outcome 
of parent management training (PMT) across different real-world prac-
tice contexts. The authors found that whether PMT was delivered to 
clinically referred or study recruited samples, in service-oriented or 
research settings, or by non-specialist or specialist therapists, there was 
no difference in the overall outcome of PMT. The findings from the 
present meta-analysis lend further support to the transportability of 
empirically supported CBT-treatments for externalizing disorders from 
university settings to routine clinical practice. The fact that the effec-
tiveness studies in the present meta-analysis seemed to have somewhat 
more severe CD/ODD samples with higher proportion of comorbid dis-
orders provide additional support for the robustness of CBT in routine 
care. 
3.1. Strengths and limitations 
A methodological strength is that a power analysis indicated that this 
meta-analysis has a high power to detect a small effect size (based on the 
number of effect sizes summarized, the mean number of participants in 
the treatment conditions, and the observed degree of heterogeneity). 
Statistical power is rarely calculated in meta-analyses, but the impor-
tance of power calculations in the interpretation of results has been 
highlighted (Hedges & Pigott, 2001, 2004). Another methodological 
strength is that all extractions of information from the included studies 
were done in pairs and any disparities were solved in consensus with all 
authors. A third strength is that the ratings of methodological quality 
and risk-of-bias was done by one of the authors and independently and 
blindly by another, yielding excellent inter rater reliability (ICC 0.94; 
0.95). Still, the most important strength of the current meta-analysis is 
that it is the first to investigate the effects of CBT for children and ad-
olescents in routine care with a diagnosis of ADHD, CD or ODD. The 
results therefore give valuable information for clinicians and decision 
makers. The findings are encouraging and indicate that externalizing 
disorders in childhood and adolescence respond well to CBT-oriented 
treatments in routine care. 
The present meta-analysis has limitations that should be considered. 
First, the quality of a meta-analysis is limited by the quality of the 
original studies and can never be better than the data it summarizes. 
Hence, an important limitation is that few studies reported measures of 
functioning or quality of life or comorbidity. Second, the judgment of 
inclusion was in some cases challenging due to poor descriptions of the 
treatment setting, the clinicians and/or referral procedures. This might 
have caused exclusion of some studies that should have been included. 
Third, titles and/or abstracts were screened by one rater only. The 
PRISMA guideline recommends the use of two independent raters when 
screening title and abstract as this procedure may reduce the possibility 
of rejecting relevant reports. However, by having two independent 
raters reading the 730 full-text articles and including 7.0% of them in 
the current meta-analyses the risk of missing out on relevant reports may 
be low. The inclusion of both RCTs and open trials is a further limitation. 
However, in the present meta-analysis we wanted to calculate the 
amount of improvement that can be achieved in routine clinical care and 
Table 10 
Effect sizes for randomized controlled studies only: ADHD and CD-ODD 
combined.  
Study type k ES 95% CI z-value Qb† p-value 
g-value at post-treatment 
Effectiveness 49 0.90 0.78–1.02  14.86a   
Efficacy 98 0.93 0.83–1.03  18.16a 0.08 0.79  
g-value at follow-up 
Effectiveness 38 0.99 0.84–1.14  13.29a   
Efficacy 57 1.09 0.96–1.21  17.05a 0.97 0.32  
Remission rate at post-treatment 
Effectiveness 25 43.9 35.2–53.1  1.30   
Efficacy 40 46.1 39.5–52.9  1.12 0.14 0.71  
Remission rate at follow-up 
Effectiveness 16 50.9 40.4–61.4  0.17   
Efficacy 25 53.7 47.0–60.4  1.08 0.19 0.66 
Note: k = number of comparisons. a p < 0.0001. Qb = Q between, † Comparison 
Effectiveness vs. Efficacy. 
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compare it with efficacy studies. Both RCTs and open trials could 
contribute with data for calculating within-group effect size and were 
therefore included. Finally, as only English-language peer-reviewed 
journal articles were included we may have missed relevant studies not 
published in peer-reviewed journals or published in languages other 
than English. 
4. Conclusion 
The findings from the present meta-analysis demonstrate the effec-
tiveness of CBT in routine clinical care for children and adolescents with 
externalizing disorders. The results showed that substantial effects can 
be obtained in routine care across different formats (i.e. individual or 
group), with different participants (i.e. parents, child or both), and with 
varying degrees of parental involvement. Finally, the results suggest that 
treatment delivered in routine care by practicing clinicians to clinically 
referred participants is as effective as treatments delivered in university 
settings. 
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